AngeloFoca, Glucophage_XR not partnered with Mallinckrodt
ohhoops mia colpa, mia colpa, mia massima colpa.
Thanxs for keeping me honest Numbers.
Whatever the specifics are... the way I broad brush reason is:
If there are 18 manufacturers... then all things considered equal, IPCI/Partner should capture ~ 5% of the market when matured... which might be 3 years time.
But it certainly could start with a .1% of the market and gain .1% on a monthly basis thereafter to arrive at 1% by years end.
We/re talking generics... so not a whole lot of marketing savvy nor expense required... it's primarily cultivating the relationship the partner has with the chain buyer.
If IPCI's partner has a ton of airline tickets to Scotland and membership at a prestigious golf course... we're set!!!
I think Generics are more like a commodity than a branded product, much the same as apples and oranges are... does anyone really ask where do they come from, who makes them???
I would not worry about IPCI's production capacity other than a few millions $ that may be required for expansion.